Barriers in Concurrent Testing for mNSCLC: Real-world Challenges and Solutions
Experts reflect on the mixed enthusiasm for concurrent liquid and tissue testing, addressing insurance coverage concerns and the importance of shortening turnaround time, while highlighting efforts to make comprehensive testing the default in the community.
Precision Oncology Molecular Genotyping Optimal Treatment Metastatic Nonsquamous Concurrent Testing Real World Challenges
Source: onclive.com